PITTSBURGH, PA--(Marketwired - Sep 6, 2016) -  InteloMed, Inc. ("InteloMed"), an emerging leader and developer of advanced non-invasive systems for patient monitoring and informatics, announced today that it has retained Healthios Capital Markets, LLC ("Healthios"), a premier investment bank focused on the global healthcare industry, as its exclusive financial advisor in connection with a Regulation D Private Placement.

"InteloMed is excited to partner with Healthios, an investment bank with unique expertise in the field of healthcare funding and a history of successful transactions," said InteloMed CEO Jill Schiaparelli. "We look forward to working with Healthios to help us grow InteloMed and empower clinical decision-making with advanced non-invasive monitoring and informatics solutions." 

About InteloMed and the CVInsight® Patient Monitoring & Informatics System
InteloMed is redefining the standard of care in patient monitoring and informatics through its CVInsight® Patient Monitoring & Informatics System, a non-invasive advanced monitoring system. It empowers clinicians with real-time, dynamic, and actionable information about a patient's cardiovascular stress level. Based on patented and proprietary algorithms, the system provides clinician-set alerts in response to changes in the patient's tolerance to illness, treatment and trauma, allowing them to provide immediate and appropriate interventions. The CVInsight® System can be used across a variety of healthcare settings and is FDA-cleared and CE-marked. The system has launched commercially in the US with initial focus in the dialysis market.

InteloMed is headquartered in Wexford, PA. For more information, visit us at www.InteloMed.com.

About Healthios Capital Markets, LLC
Healthios Capital Markets, LLC, founded in 2005 and based in Northbrook, IL, offers strategic advisory and investment banking services to emerging growth healthcare companies. 

** News, Media, PR and Content distribution provided by 1-800-PublicRelations, Inc.

Contact Information:

Contact Information
Michael Dignazio

Christoph Brandenberger
Managing Director
(Investors with accredited status only)